Published
Video length: 1 min
Asthma: a molecule that could save lives
Researchers from the CNRS of Toulouse (Haute-Garonne), Inserm and Paul-Sabatier University have identified one of the molecules causing asthma. The discovery could ultimately make it possible to better treat this disease.
(France 2)
Researchers from the CNRS of Toulouse (Haute-Garonne), Inserm and Paul-Sabatier University have identified one of the molecules causing asthma. The discovery could ultimately make it possible to better treat this disease.
It took 14 researchers and eight years of work to discover this new alarmin, the molecule which is responsible for allergies. Code name: TL1A. This molecule represents a therapeutic target of major interest for treating allergic diseases. Clinical trials will begin and a treatment could emerge within five years.
“It’s still promising”
“It’s always promising when we find a weak point in a disease. The big question is: will the drugs we are going to use not go too far and block mechanisms which naturally serve to protect and defend ourselves? This is where clinical trials in humans will give us an answer.”, confides Dr. Damien Mascret, doctor and journalist at France Télévisions. In France, 17 million people suffer from allergies, including four million asthmatics.
